Review




Structured Review

Valiant Co Ltd anti serum against mouse c3
Anti Serum Against Mouse C3, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 91/100, based on 67 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+serum+complement/IgG+Goat+Anti-Mouse+Complement+C3/pm32849588-90-19-23
Average 91 stars, based on 67 article reviews
anti serum against mouse c3 - by Bioz Stars, 2026-09
91/100 stars

Images

Related Articles

Incubation:

Article Title: Hemopexin as an Inhibitor of Hemolysis-Induced Complement Activation.
Article Snippet: Plasma FH and C3 levels were evaluated by WB using the InvitrogenTMNovexTM (ThermoFisher Scientific) separated on Bis-tris gels and transferred onto nitrocellulose membranes, using diluted plasma at 1/50. .. Next, the membranes were blocked and incubated at 4◦C overnight with an anti– human FH antiserum (Quidel, A312), an anti–serum against mouse C3 (MP Biomedicals, 0855463). .. Staining was revealed with HRP-linked secondary rabbit anti-goat antibody (Thermofisher, #31402) and detected by chemiluminescence with myECLimager R© (Thermoscientific). mRNA Level Analyses Frozen kidney sections were recovered in RLT buffer (Machereynagel) + 1% β-mercaptoethanol (Gibco, Thermoscientific) and used for mRNA extraction using RNAse-free NucleoSpin R© RNA (Macherey-nagel).

Immunohistochemistry:

Article Title: Microbiota-dependent indole production stimulates the development of collagen-induced arthritis in mice
Article Snippet: Antibody Fluorophore Clone Vendor Catalog # CD4 BUV395 GK1.5 BD Bioscience 565974 Viability Ghost Violet510 Cytek/Tonbo 13-0870-T100 CD44 BV605 IM7 Biolegend 103047 RORγt BV786 Q31-378 BD Bioscience 564723 CD25 FITC PC61.5 Cytek/Tonbo 35-0251-U025 CD3 PerCPCy5.5 145-2C11 Cytek/Tonbo 65-0031-U025 FoxP3 PE-Cy7 3G3 Cytek/Tonbo 60-5773-U025 CD62L APC-Cy7 MEL-14 Biolegend 104427 .. Antibody Use Vendor Catalog Number IgG Goat AntiMouse Complement C3 C3 IHC MP Biomedicals 0855463 Goat-on-Rodent HRP Polymer & Probe C3 IHC BioCare Medical GHP516H Anti-mouse complement C3 goat IgG fraction, peroxidase conjugated ELISA MP Biomedicals 0855557 Goat-anti-mouse IgG Fab-HRP ELISA Southern Biotech 1015-05 Goat-anti-mouse IgG1-HRP ELISA Southern Biotech 1071-05 Goat-anti-mouse IgG2a ELISA Southern Biotech 1081-05 Goat-anti-mouse IgG2b ELISA Southern Biotech 1091-05 Supplemental Figure 1. ..

Polymer:

Article Title: Microbiota-dependent indole production stimulates the development of collagen-induced arthritis in mice
Article Snippet: Antibody Fluorophore Clone Vendor Catalog # CD4 BUV395 GK1.5 BD Bioscience 565974 Viability Ghost Violet510 Cytek/Tonbo 13-0870-T100 CD44 BV605 IM7 Biolegend 103047 RORγt BV786 Q31-378 BD Bioscience 564723 CD25 FITC PC61.5 Cytek/Tonbo 35-0251-U025 CD3 PerCPCy5.5 145-2C11 Cytek/Tonbo 65-0031-U025 FoxP3 PE-Cy7 3G3 Cytek/Tonbo 60-5773-U025 CD62L APC-Cy7 MEL-14 Biolegend 104427 .. Antibody Use Vendor Catalog Number IgG Goat AntiMouse Complement C3 C3 IHC MP Biomedicals 0855463 Goat-on-Rodent HRP Polymer & Probe C3 IHC BioCare Medical GHP516H Anti-mouse complement C3 goat IgG fraction, peroxidase conjugated ELISA MP Biomedicals 0855557 Goat-anti-mouse IgG Fab-HRP ELISA Southern Biotech 1015-05 Goat-anti-mouse IgG1-HRP ELISA Southern Biotech 1071-05 Goat-anti-mouse IgG2a ELISA Southern Biotech 1081-05 Goat-anti-mouse IgG2b ELISA Southern Biotech 1091-05 Supplemental Figure 1. ..

Enzyme-linked Immunosorbent Assay:

Article Title: Microbiota-dependent indole production stimulates the development of collagen-induced arthritis in mice
Article Snippet: Antibody Fluorophore Clone Vendor Catalog # CD4 BUV395 GK1.5 BD Bioscience 565974 Viability Ghost Violet510 Cytek/Tonbo 13-0870-T100 CD44 BV605 IM7 Biolegend 103047 RORγt BV786 Q31-378 BD Bioscience 564723 CD25 FITC PC61.5 Cytek/Tonbo 35-0251-U025 CD3 PerCPCy5.5 145-2C11 Cytek/Tonbo 65-0031-U025 FoxP3 PE-Cy7 3G3 Cytek/Tonbo 60-5773-U025 CD62L APC-Cy7 MEL-14 Biolegend 104427 .. Antibody Use Vendor Catalog Number IgG Goat AntiMouse Complement C3 C3 IHC MP Biomedicals 0855463 Goat-on-Rodent HRP Polymer & Probe C3 IHC BioCare Medical GHP516H Anti-mouse complement C3 goat IgG fraction, peroxidase conjugated ELISA MP Biomedicals 0855557 Goat-anti-mouse IgG Fab-HRP ELISA Southern Biotech 1015-05 Goat-anti-mouse IgG1-HRP ELISA Southern Biotech 1071-05 Goat-anti-mouse IgG2a ELISA Southern Biotech 1081-05 Goat-anti-mouse IgG2b ELISA Southern Biotech 1091-05 Supplemental Figure 1. ..

other:

Article Title: Overexpression of schizophrenia susceptibility factor human complement C4A promotes excessive synaptic loss and behavioral changes in mice.
Article Snippet: Materials & experimental systems n/a Involved in the study Antibodies Eukaryotic cell lines Palaeontology and archaeology Animals and other organisms Human research participants Clinical data Dual use research of concern Methods n/a Involved in the study ChIP-seq Flow cytometry MRI-based neuroimaging Antibodies Antibodies used Antibodies used in the study are provided blow in the format (Host species α- target protein; [Clone - when applicable]; (Conjugation - when applicable); Manufacturer; Catalog #; Lot #; Use in study (dilution)): Rabbit α-hC4c; Dako; F0169; 20030271; IHC (1:500), ELISA (1:1000), FACS (1:200) Goat antiserum to hC4; Quidel; A305; 136829; ELISA (1:1000) Goat α-mC3; MP Biomedicals; 0855463; 07503; ELISA (1:1000) Rabbit α-mC3; Abcam; Ab11887; GR3333817-4; ELISA (1:1000) Rabbit α-hC3d; Dako; A0063; 00005390; IHC (1:500) Rat α-C1q; [7H8]; Abcam; Ab11861; GR3284291; ELISA (1:500), FACS (1:200) Rabbit α-C1q; Abcam; Ab182451; GR3266536-3; ELISA (1:500) Mouse α-NeuN; [A60]; Millipore; MAB377; 2967854; IHC (1:300) Mouse α-SV2; Developmental Studies Hybridoma Bank, U of Iowa; AB2315387; IHC (1:1000), WB (1:1000), FACS (1:1000) 3 n atu re research | rep o rtin g su m m ary A p ril 2 0 2 0 Rabbit α-Homer1; Synaptic Systems; 160003; 160003-1-41; IHC (1:1000), WB (1:1000) Rabbit α-Iba1; Wako; 019-19741; CAK1997; IHC (1:300) Rat α-CD68; (AF488 Conj); BioLegend; 137012; B229996; IHC (1:300), FACS (1:400) Guinea pig α- VGlut2; Millipore; AB2251-I;3083563; IHC (1:1000) Rabbit α-GAPDH; BioLegend; 631401; B225532; WB (1:500) Rat α-mC4; [16D2]; Gift of E. Kremmer; ELISA (1:1000) Mouse α-Brn3a; [14A6]; Santa Cruz Biotechnology; SC-8429; IHC (1:100) Rat α-CD21/35; [7E9]; (Pac Blue); BioLegend; 123414; B273685; IHC (1:300) Rat α-CD169; (FITC); BioLegend; 142406; IHC (1:300) Rat α-CD11b; [M1/70]; (PE); BioLegend; 101208; B253922; FACS (1:400) Rat α-CD45; [30-F11]; (PE Cy7); BioLegend; 103114; B243728; FACS (1:200) Validation All antibodies used in the study was validated by previously published studies, the manufacturers, or in this paper by the use of appropriate positive and negative controls with genetically modified mice.



Similar Products

93
Innovative Research Inc c57bl 6 mouse serum
C57bl 6 Mouse Serum, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+serum+complement/Innovative+Grade+US+Origin+Mouse+C57BL6+Complement+Serum/pmc12418739-232-16-23
Average 93 stars, based on 1 article reviews
c57bl 6 mouse serum - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

95
Cedarlane heat inactivated terminal mouse serum
A-C: Protein ELISA measuring reactivity of TbpB, C-lobe, and LCL-immune sera against full-length TbpB, TbpB C-lobe, and TbpB N-lobe, respectively. D: IgG titre elicited by the different immunogens towards heat <t>inactivated</t> Nme M982. A-D: N=10-15 per group; squares represent pre-challenge sera from C57BL/6 animals from the sepsis study presented in ; circles represent terminal serum from hCEACAM1 FvB mice from the colonization study presented in , each symbol represents serum from one animal tested in duplicate. E: Serum bactericidal activity (SBA) titre against iron-starved Nme M982. N=19-25 per group, including terminal hCEACAM1 FvB serum from , plus additional terminal serum from immunized hCEACAM1 FvB from pilot studies. SBA titre (>50% killing) reached for 19/25 (76%) TbpB, 8/19 (42%) C-lobe, 14/22 (64%) LCL and 3/21 (14%) Alum samples. Dotted lines represent lowest dilution tested. Line at median for each group. One-way ANOVA with Tukey’s post-hoc test comparing each group to every other group performed using GraphPad Prism 10.2.0. For D, E: Statistics performed on Log2 transformed data. ns, not significant; **, p<0.01; ***, p<0.001; ****, p<0.0001. F: Meningococcal growth inhibition assay. Iron-starved M982 strain was grown in the presence of hTf and pooled heat-inactivated serum from TbpB, C-lobe and LCL immunized animals from . Change in absorbance (OD600) relative to the initial time point is graphed; error bars depict standard deviation of two technical replicates.
Heat Inactivated Terminal Mouse Serum, supplied by Cedarlane, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+serum+complement/Baby+Rabbit+Complement%2C+Sterile%2C+Frozen/bio_rxiv__2025__10__30__685603-203-26-19
Average 95 stars, based on 1 article reviews
heat inactivated terminal mouse serum - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

90
Thermo Fisher antiserum/complement mixture (1:20 dilution of the serum and 20% of mouse complement
A-C: Protein ELISA measuring reactivity of TbpB, C-lobe, and LCL-immune sera against full-length TbpB, TbpB C-lobe, and TbpB N-lobe, respectively. D: IgG titre elicited by the different immunogens towards heat <t>inactivated</t> Nme M982. A-D: N=10-15 per group; squares represent pre-challenge sera from C57BL/6 animals from the sepsis study presented in ; circles represent terminal serum from hCEACAM1 FvB mice from the colonization study presented in , each symbol represents serum from one animal tested in duplicate. E: Serum bactericidal activity (SBA) titre against iron-starved Nme M982. N=19-25 per group, including terminal hCEACAM1 FvB serum from , plus additional terminal serum from immunized hCEACAM1 FvB from pilot studies. SBA titre (>50% killing) reached for 19/25 (76%) TbpB, 8/19 (42%) C-lobe, 14/22 (64%) LCL and 3/21 (14%) Alum samples. Dotted lines represent lowest dilution tested. Line at median for each group. One-way ANOVA with Tukey’s post-hoc test comparing each group to every other group performed using GraphPad Prism 10.2.0. For D, E: Statistics performed on Log2 transformed data. ns, not significant; **, p<0.01; ***, p<0.001; ****, p<0.0001. F: Meningococcal growth inhibition assay. Iron-starved M982 strain was grown in the presence of hTf and pooled heat-inactivated serum from TbpB, C-lobe and LCL immunized animals from . Change in absorbance (OD600) relative to the initial time point is graphed; error bars depict standard deviation of two technical replicates.
Antiserum/Complement Mixture (1:20 Dilution Of The Serum And 20% Of Mouse Complement, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+serum+complement/pm39370617-339-12-26
Average 90 stars, based on 1 article reviews
antiserum/complement mixture (1:20 dilution of the serum and 20% of mouse complement - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

93
Innovative Research Inc c57bl6 mouse complement mc source
A-C: Protein ELISA measuring reactivity of TbpB, C-lobe, and LCL-immune sera against full-length TbpB, TbpB C-lobe, and TbpB N-lobe, respectively. D: IgG titre elicited by the different immunogens towards heat <t>inactivated</t> Nme M982. A-D: N=10-15 per group; squares represent pre-challenge sera from C57BL/6 animals from the sepsis study presented in ; circles represent terminal serum from hCEACAM1 FvB mice from the colonization study presented in , each symbol represents serum from one animal tested in duplicate. E: Serum bactericidal activity (SBA) titre against iron-starved Nme M982. N=19-25 per group, including terminal hCEACAM1 FvB serum from , plus additional terminal serum from immunized hCEACAM1 FvB from pilot studies. SBA titre (>50% killing) reached for 19/25 (76%) TbpB, 8/19 (42%) C-lobe, 14/22 (64%) LCL and 3/21 (14%) Alum samples. Dotted lines represent lowest dilution tested. Line at median for each group. One-way ANOVA with Tukey’s post-hoc test comparing each group to every other group performed using GraphPad Prism 10.2.0. For D, E: Statistics performed on Log2 transformed data. ns, not significant; **, p<0.01; ***, p<0.001; ****, p<0.0001. F: Meningococcal growth inhibition assay. Iron-starved M982 strain was grown in the presence of hTf and pooled heat-inactivated serum from TbpB, C-lobe and LCL immunized animals from . Change in absorbance (OD600) relative to the initial time point is graphed; error bars depict standard deviation of two technical replicates.
C57bl6 Mouse Complement Mc Source, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+serum+complement/Innovative+Grade+US+Origin+Mouse+C57BL6+Complement+Serum/pm34696934-113-23-28
Average 93 stars, based on 1 article reviews
c57bl6 mouse complement mc source - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

90
Innovative Research Inc c57bl/6 mouse complement serum
A-C: Protein ELISA measuring reactivity of TbpB, C-lobe, and LCL-immune sera against full-length TbpB, TbpB C-lobe, and TbpB N-lobe, respectively. D: IgG titre elicited by the different immunogens towards heat <t>inactivated</t> Nme M982. A-D: N=10-15 per group; squares represent pre-challenge sera from C57BL/6 animals from the sepsis study presented in ; circles represent terminal serum from hCEACAM1 FvB mice from the colonization study presented in , each symbol represents serum from one animal tested in duplicate. E: Serum bactericidal activity (SBA) titre against iron-starved Nme M982. N=19-25 per group, including terminal hCEACAM1 FvB serum from , plus additional terminal serum from immunized hCEACAM1 FvB from pilot studies. SBA titre (>50% killing) reached for 19/25 (76%) TbpB, 8/19 (42%) C-lobe, 14/22 (64%) LCL and 3/21 (14%) Alum samples. Dotted lines represent lowest dilution tested. Line at median for each group. One-way ANOVA with Tukey’s post-hoc test comparing each group to every other group performed using GraphPad Prism 10.2.0. For D, E: Statistics performed on Log2 transformed data. ns, not significant; **, p<0.01; ***, p<0.001; ****, p<0.0001. F: Meningococcal growth inhibition assay. Iron-starved M982 strain was grown in the presence of hTf and pooled heat-inactivated serum from TbpB, C-lobe and LCL immunized animals from . Change in absorbance (OD600) relative to the initial time point is graphed; error bars depict standard deviation of two technical replicates.
C57bl/6 Mouse Complement Serum, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+serum+complement/10__1128_slash_iai__00454___21-330-74-69
Average 90 stars, based on 1 article reviews
c57bl/6 mouse complement serum - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

93
Innovative Research Inc c57bl 6 mouse complement serum
A-C: Protein ELISA measuring reactivity of TbpB, C-lobe, and LCL-immune sera against full-length TbpB, TbpB C-lobe, and TbpB N-lobe, respectively. D: IgG titre elicited by the different immunogens towards heat <t>inactivated</t> Nme M982. A-D: N=10-15 per group; squares represent pre-challenge sera from C57BL/6 animals from the sepsis study presented in ; circles represent terminal serum from hCEACAM1 FvB mice from the colonization study presented in , each symbol represents serum from one animal tested in duplicate. E: Serum bactericidal activity (SBA) titre against iron-starved Nme M982. N=19-25 per group, including terminal hCEACAM1 FvB serum from , plus additional terminal serum from immunized hCEACAM1 FvB from pilot studies. SBA titre (>50% killing) reached for 19/25 (76%) TbpB, 8/19 (42%) C-lobe, 14/22 (64%) LCL and 3/21 (14%) Alum samples. Dotted lines represent lowest dilution tested. Line at median for each group. One-way ANOVA with Tukey’s post-hoc test comparing each group to every other group performed using GraphPad Prism 10.2.0. For D, E: Statistics performed on Log2 transformed data. ns, not significant; **, p<0.01; ***, p<0.001; ****, p<0.0001. F: Meningococcal growth inhibition assay. Iron-starved M982 strain was grown in the presence of hTf and pooled heat-inactivated serum from TbpB, C-lobe and LCL immunized animals from . Change in absorbance (OD600) relative to the initial time point is graphed; error bars depict standard deviation of two technical replicates.
C57bl 6 Mouse Complement Serum, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+serum+complement/Innovative+Grade+US+Origin+Mouse+C57BL6+Complement+Serum/10__1128_slash_iai__00454___21-330-65-69
Average 93 stars, based on 1 article reviews
c57bl 6 mouse complement serum - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

96
Valiant Co Ltd mouse complement c3
A-C: Protein ELISA measuring reactivity of TbpB, C-lobe, and LCL-immune sera against full-length TbpB, TbpB C-lobe, and TbpB N-lobe, respectively. D: IgG titre elicited by the different immunogens towards heat <t>inactivated</t> Nme M982. A-D: N=10-15 per group; squares represent pre-challenge sera from C57BL/6 animals from the sepsis study presented in ; circles represent terminal serum from hCEACAM1 FvB mice from the colonization study presented in , each symbol represents serum from one animal tested in duplicate. E: Serum bactericidal activity (SBA) titre against iron-starved Nme M982. N=19-25 per group, including terminal hCEACAM1 FvB serum from , plus additional terminal serum from immunized hCEACAM1 FvB from pilot studies. SBA titre (>50% killing) reached for 19/25 (76%) TbpB, 8/19 (42%) C-lobe, 14/22 (64%) LCL and 3/21 (14%) Alum samples. Dotted lines represent lowest dilution tested. Line at median for each group. One-way ANOVA with Tukey’s post-hoc test comparing each group to every other group performed using GraphPad Prism 10.2.0. For D, E: Statistics performed on Log2 transformed data. ns, not significant; **, p<0.01; ***, p<0.001; ****, p<0.0001. F: Meningococcal growth inhibition assay. Iron-starved M982 strain was grown in the presence of hTf and pooled heat-inactivated serum from TbpB, C-lobe and LCL immunized animals from . Change in absorbance (OD600) relative to the initial time point is graphed; error bars depict standard deviation of two technical replicates.
Mouse Complement C3, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+serum+complement/Mouse+serum/pm34211460-52-36-39
Average 96 stars, based on 1 article reviews
mouse complement c3 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

91
Valiant Co Ltd anti serum against mouse c3
A-C: Protein ELISA measuring reactivity of TbpB, C-lobe, and LCL-immune sera against full-length TbpB, TbpB C-lobe, and TbpB N-lobe, respectively. D: IgG titre elicited by the different immunogens towards heat <t>inactivated</t> Nme M982. A-D: N=10-15 per group; squares represent pre-challenge sera from C57BL/6 animals from the sepsis study presented in ; circles represent terminal serum from hCEACAM1 FvB mice from the colonization study presented in , each symbol represents serum from one animal tested in duplicate. E: Serum bactericidal activity (SBA) titre against iron-starved Nme M982. N=19-25 per group, including terminal hCEACAM1 FvB serum from , plus additional terminal serum from immunized hCEACAM1 FvB from pilot studies. SBA titre (>50% killing) reached for 19/25 (76%) TbpB, 8/19 (42%) C-lobe, 14/22 (64%) LCL and 3/21 (14%) Alum samples. Dotted lines represent lowest dilution tested. Line at median for each group. One-way ANOVA with Tukey’s post-hoc test comparing each group to every other group performed using GraphPad Prism 10.2.0. For D, E: Statistics performed on Log2 transformed data. ns, not significant; **, p<0.01; ***, p<0.001; ****, p<0.0001. F: Meningococcal growth inhibition assay. Iron-starved M982 strain was grown in the presence of hTf and pooled heat-inactivated serum from TbpB, C-lobe and LCL immunized animals from . Change in absorbance (OD600) relative to the initial time point is graphed; error bars depict standard deviation of two technical replicates.
Anti Serum Against Mouse C3, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+serum+complement/IgG+Goat+Anti-Mouse+Complement+C3/pm32849588-90-19-23
Average 91 stars, based on 1 article reviews
anti serum against mouse c3 - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier

Image Search Results


A-C: Protein ELISA measuring reactivity of TbpB, C-lobe, and LCL-immune sera against full-length TbpB, TbpB C-lobe, and TbpB N-lobe, respectively. D: IgG titre elicited by the different immunogens towards heat inactivated Nme M982. A-D: N=10-15 per group; squares represent pre-challenge sera from C57BL/6 animals from the sepsis study presented in ; circles represent terminal serum from hCEACAM1 FvB mice from the colonization study presented in , each symbol represents serum from one animal tested in duplicate. E: Serum bactericidal activity (SBA) titre against iron-starved Nme M982. N=19-25 per group, including terminal hCEACAM1 FvB serum from , plus additional terminal serum from immunized hCEACAM1 FvB from pilot studies. SBA titre (>50% killing) reached for 19/25 (76%) TbpB, 8/19 (42%) C-lobe, 14/22 (64%) LCL and 3/21 (14%) Alum samples. Dotted lines represent lowest dilution tested. Line at median for each group. One-way ANOVA with Tukey’s post-hoc test comparing each group to every other group performed using GraphPad Prism 10.2.0. For D, E: Statistics performed on Log2 transformed data. ns, not significant; **, p<0.01; ***, p<0.001; ****, p<0.0001. F: Meningococcal growth inhibition assay. Iron-starved M982 strain was grown in the presence of hTf and pooled heat-inactivated serum from TbpB, C-lobe and LCL immunized animals from . Change in absorbance (OD600) relative to the initial time point is graphed; error bars depict standard deviation of two technical replicates.

Journal: bioRxiv

Article Title: Rationally designed minimized TbpB confers broad protection against meningococcal infection

doi: 10.1101/2025.10.30.685603

Figure Lengend Snippet: A-C: Protein ELISA measuring reactivity of TbpB, C-lobe, and LCL-immune sera against full-length TbpB, TbpB C-lobe, and TbpB N-lobe, respectively. D: IgG titre elicited by the different immunogens towards heat inactivated Nme M982. A-D: N=10-15 per group; squares represent pre-challenge sera from C57BL/6 animals from the sepsis study presented in ; circles represent terminal serum from hCEACAM1 FvB mice from the colonization study presented in , each symbol represents serum from one animal tested in duplicate. E: Serum bactericidal activity (SBA) titre against iron-starved Nme M982. N=19-25 per group, including terminal hCEACAM1 FvB serum from , plus additional terminal serum from immunized hCEACAM1 FvB from pilot studies. SBA titre (>50% killing) reached for 19/25 (76%) TbpB, 8/19 (42%) C-lobe, 14/22 (64%) LCL and 3/21 (14%) Alum samples. Dotted lines represent lowest dilution tested. Line at median for each group. One-way ANOVA with Tukey’s post-hoc test comparing each group to every other group performed using GraphPad Prism 10.2.0. For D, E: Statistics performed on Log2 transformed data. ns, not significant; **, p<0.01; ***, p<0.001; ****, p<0.0001. F: Meningococcal growth inhibition assay. Iron-starved M982 strain was grown in the presence of hTf and pooled heat-inactivated serum from TbpB, C-lobe and LCL immunized animals from . Change in absorbance (OD600) relative to the initial time point is graphed; error bars depict standard deviation of two technical replicates.

Article Snippet: Assay was set up in 40 μL total volume using ∼500 bacteria suspended in PBS++, 10% baby rabbit complement (Cedarlane, CL3441-S100) and 2-fold serial dilutions of heat inactivated terminal mouse serum.

Techniques: Enzyme-linked Immunosorbent Assay, Activity Assay, Transformation Assay, Growth Inhibition Assay, Standard Deviation

A: Phylogenetic tree depicting Neisserial TbpB diversity. The location of M982 TbpB is highlighted, along with 16 additional TbpBs spanning various clusters used for cross-reactivity analysis. B: Heat map depicting IgG cross-reactivity against a broad panel of TbpB protein variants by ELISA. Optical density (OD) readings denoted by the colour gradient. Background noise from no-protein control subtracted. Each row is a different TbpB protein capture, with the phylogenetic cluster indicated to the left. Each column is a different mouse sample, with the immunizing antigens indicated above. Numbered labels starting with A are pre-challenge serum from the immunized C67BL/6 sepsis cohort; B are terminal serum from the immunized hCEACAM1 FvB colonization cohort. C: Grouped bar graph summarizing cross-reactive antibody data from B. Bars represent mean, error bars represent standard error, each circle represents serum from a single mouse (N=8 for immune sera, N=3 for Alum). hTf-HRP signal quantifying properly folded TbpB capture is depicted in the inset, mean ± standard deviation. D: Serum reactivity against representative Nme and Ngo strains grown under iron limitation using inactivated whole bacterial ELISA. TbpB cluster indicated below the x-axis. Background noise from no serum control subtracted. Bars represent mean, error bars represent standard error, each circle represents serum from a single mouse, N=5-8/group. Inset depicts hTf-binding as an indicator of TbpAB receptor expression on bacteria used for coating ELISA plates, mean ± standard deviation. For C and D, two-way ANOVA with Dunnett’s post-hoc test comparing each group to Alum control performed using GraphPad Prism 10.2.0. Only p-values <0.05 shown. *, p<0.05; **, p<0.01; ***, p<0.001, ****, p<0.0001.

Journal: bioRxiv

Article Title: Rationally designed minimized TbpB confers broad protection against meningococcal infection

doi: 10.1101/2025.10.30.685603

Figure Lengend Snippet: A: Phylogenetic tree depicting Neisserial TbpB diversity. The location of M982 TbpB is highlighted, along with 16 additional TbpBs spanning various clusters used for cross-reactivity analysis. B: Heat map depicting IgG cross-reactivity against a broad panel of TbpB protein variants by ELISA. Optical density (OD) readings denoted by the colour gradient. Background noise from no-protein control subtracted. Each row is a different TbpB protein capture, with the phylogenetic cluster indicated to the left. Each column is a different mouse sample, with the immunizing antigens indicated above. Numbered labels starting with A are pre-challenge serum from the immunized C67BL/6 sepsis cohort; B are terminal serum from the immunized hCEACAM1 FvB colonization cohort. C: Grouped bar graph summarizing cross-reactive antibody data from B. Bars represent mean, error bars represent standard error, each circle represents serum from a single mouse (N=8 for immune sera, N=3 for Alum). hTf-HRP signal quantifying properly folded TbpB capture is depicted in the inset, mean ± standard deviation. D: Serum reactivity against representative Nme and Ngo strains grown under iron limitation using inactivated whole bacterial ELISA. TbpB cluster indicated below the x-axis. Background noise from no serum control subtracted. Bars represent mean, error bars represent standard error, each circle represents serum from a single mouse, N=5-8/group. Inset depicts hTf-binding as an indicator of TbpAB receptor expression on bacteria used for coating ELISA plates, mean ± standard deviation. For C and D, two-way ANOVA with Dunnett’s post-hoc test comparing each group to Alum control performed using GraphPad Prism 10.2.0. Only p-values <0.05 shown. *, p<0.05; **, p<0.01; ***, p<0.001, ****, p<0.0001.

Article Snippet: Assay was set up in 40 μL total volume using ∼500 bacteria suspended in PBS++, 10% baby rabbit complement (Cedarlane, CL3441-S100) and 2-fold serial dilutions of heat inactivated terminal mouse serum.

Techniques: Enzyme-linked Immunosorbent Assay, Control, Standard Deviation, Binding Assay, Expressing, Bacteria